Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rocket Pharmaceuticals Inc (NQ: RCKT )

32.56 USD +0.12 (+0.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 245,612
Open 32.74
Bid (Size) 30.00 (1)
Ask (Size) 40.00 (4)
Prev. Close 32.44
Today's Range 32.47 - 33.19
52wk Range 22.04 - 67.48
Shares Outstanding 63,615,685
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces an oral... 
From Business Wire News Releases
Rocket Pharmaceuticals Announces Upcoming Danon Disease Presentation at the Heart Failure Society of America Annual Scientific Meeting 2021
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that previously... 
From Business Wire News Releases

Performance

YTD
-42.36%
-42.36%
1 Month
+7.81%
+7.81%
3 Month
-25.37%
-25.37%
6 Month
-41.13%
-41.13%
1 Year
+36.29%
+36.29%

More News

Read More
Rocket Pharmaceuticals Appoints Isabel Carmona, J.D., as Chief Human Resources Officer
From Business Wire News Releases
Rocket Pharmaceuticals Announces $26.4 Million Private Placement
From Business Wire News Releases
Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501
From Business Wire News Releases
Rocket Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Progress
From Business Wire News Releases
Rocket Pharmaceuticals to Host Conference Call on Aug. 9 at 4:30 p.m. ET to Discuss Second Quarter Results and Recent Business Highlights
From Business Wire News Releases
Rocket Pharmaceuticals is Now Oversold (RCKT)
Tags Stocks
From Market News Video
FDA Lifts Clinical Hold On Rocket Pharma's X-Linked Inherited Disorder Trial
Tags Small Cap Biotech RCKT
From Benzinga
First Week of RCKT September 17th Options Trading
Tags Stocks
From Market News Video
Surprising Analyst 12-Month Target For WDNA
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.